OBGYN Flashcards
CIN types
CIN 1: mild, lower 1/3
CIN 2: moderate, lower 2/3
CIN 3: severe, over 2/3
Gardasil vaccine
Recommended at age 11-12 (from Hannah’s quizlet)
Age 9-14: 2-dose - 0 months and 6-12 months OR 3-dose - 0, 2, 6 months
Age 15-45: 3-dose (0, 2, 6 months)
(from Epperly’s slides)
Cervical cancer screening
Start at age 21
Pap every 3 years until 30
Pap & HPV every 5 years from 30-65 OR pap only every 3 years
When to stop screening for cervical cancer?
65+
No hx of moderate or severe dysplasia
3 negative paps in a row
Pap smear results
ASCUS (undetermined significance)
ASCH (cannot exclude high-grade lesion)
LGSIL (low-grade squamous intraepithelial, corresponds to CIN 1)
HGSIL (high-grade squamous intraepithelial, corresponds to CIN 2/3)
AGC (atypical glandular cells)
Treatment of ASCUS
Repeat paps every 6 months until normal
Next step for LGSIL and HGSIL
Colposcopy and biopsy
Treatment of CIN 1
Expectant management
2 paps every 6 months or pap & HPV test every 6 months
Treatment of CIN 2 or 3
Surgical procedure
HPV strains most correlated with cervical cancer
16, 18, 45
S/S of cervical cancer
Abnormal vaginal bleeding
*Postcoital bleeding
Treatment of cervical cancer
Radical hysterectomy and lymphadenectomy
Most common gyn malignancy
Endometrial cancer
Risk factors for endometrial cancer
Unopposed estrogen
Obesity
Risk reduction for endometrial cancer
Combo OCP use
Smoking
S/S of endometrial cancer
Abnormal uterine bleeding
MCC of endometrial cancer
Adenocarcinoma
Diagnosis of endometrial cancer
US first
Biopsy
Treatment of endometrial cancer
Total hysterectomy with bilateral salpingo-oopherectomy
Lactational amenorrhea
Exclusive breastfeeding leading to amenorrhea and contraception
MOA of OCP
Ovulation suppression
Benefits of combination OCP use
Reduced endometrial and ovarian cancer
Increase bone mass
Acne improvements
Dysmenorrhea improvement